Takeda Pharmaceutical Company Limited (TAK)

Takeda Pharmaceutical Income Statement

Financials in millions JPY. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Revenue	4,263,762	4,027,478	3,569,006	3,197,812	3,291,188
Revenue Growth (YoY)	5.87%	12.85%	11.61%	-2.84%	56.93%
Cost of Revenue	1,426,678	1,244,072	1,106,846	994,308	1,089,764
Gross Profit	2,837,084	2,783,406	2,462,160	2,203,504	2,201,424
Selling, General & Admin	1,053,819	997,309	886,361	875,663	964,737
Research & Development	729,924	633,325	526,087	455,833	492,381
Other Operating Expenses	839,265	662,266	588,867	362,739	643,898
Operating Expenses	2,623,008	2,292,900	2,001,315	1,694,235	2,101,016
Operating Income	214,076	490,506	460,845	509,269	100,408
Interest Expense / Income	219,850	169,698	166,607	248,631	165,006
Other Expense / Income	-58,435	-54,261	-8,226	-105,431	-3,795
Pretax Income	52,661	375,069	302,464	366,069	-60,803
Income Tax	-91,406	58,052	72,405	-9,936	-105,044
Net Income	144,067	317,017	230,059	376,005	44,241
Net Income Growth	-54.56%	37.80%	-38.81%	749.90%	-67.28%
Shares Outstanding (Basic)	1,569	1,550	1,563	1,558	1,565
Shares Change	1.20%	-0.83%	0.36%	-0.46%	99.75%
EPS (Basic)	46.05	102.14	73.57	120.36	14.21
EPS (Diluted)	45.58	100.97	72.94	119.48	14.13
EPS Growth	-54.86%	38.44%	-38.96%	745.88%	-79.80%
Free Cash Flow	549,530	837,461	1,001,668	946,178	555,248
Free Cash Flow Per Share	175.13	270.09	320.36	303.70	177.40
Gross Margin	66.54%	69.11%	68.99%	68.91%	66.89%
Operating Margin	5.02%	12.18%	12.91%	15.93%	3.05%
Profit Margin	3.38%	7.87%	6.45%	11.76%	1.34%
Free Cash Flow Margin	12.89%	20.79%	28.07%	29.59%	16.87%
Effective Tax Rate	-173.57%	15.48%	23.94%	-2.71%	-
EBITDA	1,000,513	1,209,167	1,052,222	1,174,371	687,852
EBITDA Margin	23.47%	30.02%	29.48%	36.72%	20.90%
Depreciation & Amortization	728,002	664,400	583,151	559,671	583,649
EBIT	272,511	544,767	469,071	614,700	104,203
EBIT Margin	6.39%	13.53%	13.14%	19.22%	3.17%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).